Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group.
Steinherz PG, Gaynon P, Miller DR, Reaman G, Bleyer A, Finklestein J, Evans RG, Meyers P, Steinherz LJ, Sather H, et al. Steinherz PG, et al. Among authors: steinherz lj. J Clin Oncol. 1986 May;4(5):744-52. doi: 10.1200/JCO.1986.4.5.744. J Clin Oncol. 1986. PMID: 3517244 Clinical Trial.
Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
Heath JA, Steinherz PG, Altman A, Sather H, Jhanwar S, Halpern S, Pieters R, Shah N, Steinherz L, Tannous R, Terry W, Trigg ME; Children's Cancer Group. Heath JA, et al. Among authors: steinherz pg, steinherz l. J Clin Oncol. 2003 Apr 15;21(8):1612-7. doi: 10.1200/JCO.2003.07.129. J Clin Oncol. 2003. PMID: 12697887 Clinical Trial.
Modified BFM therapy for children with previously untreated acute lymphoblastic leukemia and unfavorable prognostic features. Report of Children's Cancer Study Group Study CCG-193P.
Gaynon PS, Bleyer WA, Steinherz PG, Finklestein JZ, Littman PS, Miller DR, Reaman GH, Sather HN, Hammond GD. Gaynon PS, et al. Among authors: steinherz pg. Am J Pediatr Hematol Oncol. 1988 Spring;10(1):42-50. doi: 10.1097/00043426-198821000-00009. Am J Pediatr Hematol Oncol. 1988. PMID: 3056061 Clinical Trial.
Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group Study CCG-106.
Gaynon PS, Steinherz PG, Bleyer WA, Ablin AR, Albo VC, Finklestein JZ, Grossman NJ, Novak LJ, Pyesmany AF, Reaman GH, et al. Gaynon PS, et al. Among authors: steinherz pg. J Clin Oncol. 1993 Nov;11(11):2234-42. doi: 10.1200/JCO.1993.11.11.2234. J Clin Oncol. 1993. PMID: 8229139 Clinical Trial.
Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group.
Reaman GH, Sposto R, Sensel MG, Lange BJ, Feusner JH, Heerema NA, Leonard M, Holmes EJ, Sather HN, Pendergrass TW, Johnstone HS, O'Brien RT, Steinherz PG, Zeltzer PM, Gaynon PS, Trigg ME, Uckun FM. Reaman GH, et al. Among authors: steinherz pg. J Clin Oncol. 1999 Feb;17(2):445-55. doi: 10.1200/JCO.1999.17.2.445. J Clin Oncol. 1999. PMID: 10080584 Clinical Trial.
Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
Jeha S, Gaynon PS, Razzouk BI, Franklin J, Kadota R, Shen V, Luchtman-Jones L, Rytting M, Bomgaars LR, Rheingold S, Ritchey K, Albano E, Arceci RJ, Goldman S, Griffin T, Altman A, Gordon B, Steinherz L, Weitman S, Steinherz P. Jeha S, et al. J Clin Oncol. 2006 Apr 20;24(12):1917-23. doi: 10.1200/JCO.2005.03.8554. J Clin Oncol. 2006. PMID: 16622268 Clinical Trial.
176 results